US Broker Ratings

Omnicell, Inc. (OMCL): Investor Outlook Reveals 45% Upside Potential

Omnicell, Inc. (NASDAQ: OMCL), a prominent player in the healthcare sector, specifically within the Health Information Services industry, is drawing attention from investors with its robust..

U.S. Physical Therapy, Inc. (USPH): Analyst Consensus Shows 19.39% Upside Potential

U.S. Physical Therapy, Inc. (NYSE: USPH) presents an intriguing opportunity for investors with an eye on the healthcare sector, specifically within the medical care facilities industry...

Xenon Pharmaceuticals Inc. (XENE) Stock Analysis: Exploring a 26.68% Potential Upside in the Biotech Sector

Xenon Pharmaceuticals Inc. (NASDAQ: XENE) stands out in the biotechnology industry with its focus on developing innovative treatments for neurological and psychiatric disorders. Headquartered in Burnaby,..

Ardent Health, Inc. (ARDT) Stock Analysis: A 29.77% Potential Upside in the Healthcare Sector

Ardent Health, Inc. (ARDT) is making waves in the healthcare sector with a promising potential upside of nearly 30%. Investors looking to capitalize on growth within..

Azenta, Inc. (AZTA) Stock Analysis: Navigating a Transformative Path with a 7.17% Potential Upside

Azenta, Inc. (NASDAQ: AZTA) is carving a niche in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.45..

GoodRx Holdings, Inc. (GDRX) Stock Analysis: Exploring a 35% Upside Potential Amidst Healthcare Innovation

GoodRx Holdings, Inc. (GDRX), a key player in the healthcare sector, stands out in the health information services industry with its innovative approach to helping consumers..

MannKind Corporation (MNKD) Investor Outlook: Exploring an 88.98% Potential Upside

MannKind Corporation (NASDAQ: MNKD) stands at a fascinating juncture in its trajectory, offering investors a potential upside of 88.98%, according to recent analyst ratings. This biopharmaceutical..

Crinetics Pharmaceuticals (CRNX) Stock Analysis: A Biotech with 89% Potential Upside

Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is making waves in the biotechnology sector with a market cap of $4 billion and a current stock price of $42.45...

ACADIA Pharmaceuticals Inc. (ACAD) Investor Outlook: A 37% Upside Potential Amid CNS Drug Innovations

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a prominent player in the biotechnology sector, has piqued investor interest with its strategic focus on central nervous system (CNS) disorders..

UFP Technologies, Inc. (UFPT) Stock Analysis: A 67% Potential Upside in the Booming Medical Devices Sector

UFP Technologies, Inc. (NASDAQ: UFPT) is making waves in the healthcare sector, specifically within the medical devices industry. With its headquarters in Newburyport, Massachusetts, the company..

Indivior PLC (INDV) Stock Analysis: Exploring a 20% Upside Potential in the Healthcare Sector

Indivior PLC (NASDAQ: INDV), a key player in the healthcare sector, has been making waves with its specialized focus on developing treatments for opioid dependence and..

Ligand Pharmaceuticals (LGND) Stock Analysis: Exploring Healthcare Innovation and Market Dynamics

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND) stands as a compelling player in the biotechnology sector, presenting a diverse portfolio of biopharmaceutical assets that captivates investors with its..

Phreesia, Inc. (PHR) Stock Analysis: Unpacking a 47% Upside Potential for Investors

Phreesia, Inc. (PHR), a notable player in the Healthcare sector, is attracting attention from investors with its compelling growth narrative and a significant upside potential. As..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: A Biotech Player with a Promising 213% Upside Potential

Investors seeking opportunities in the biotechnology sector may find ARS Pharmaceuticals, Inc. (NASDAQ: SPRY) an intriguing prospect. With a market capitalization of $993.2 million, this San..

NewAmsterdam Pharma (NAMS) Stock Analysis: A Biotech Powerhouse with 740% Revenue Growth and Strong Buy Ratings

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), a Netherlands-based biotechnology firm, stands out in the healthcare sector with its promising therapeutic developments and impressive revenue growth figures...

Addus HomeCare Corporation (ADUS) Stock Analysis: A 16.87% Potential Upside in the Healthcare Sector

Addus HomeCare Corporation (NASDAQ: ADUS) is a prominent player in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $2.24..

Alphatec Holdings, Inc. (ATEC) Stock Analysis: Exploring a 24.84% Potential Upside

Alphatec Holdings, Inc. (ATEC), a key player in the healthcare sector with a focus on medical devices, is capturing investor attention with its innovative approach to..

Premier, Inc. (PINC) Stock Analysis: Navigating Stability in Healthcare with a Steady Dividend Yield

Premier, Inc. (NASDAQ: PINC) stands as a noteworthy player in the healthcare sector, specifically within the health information services industry. With a market capitalization of $2.32..

Adaptive Biotechnologies (ADPT): Stock Analysis Reveals Strong Revenue Growth Amid Challenging Valuation

Adaptive Biotechnologies Corporation (NASDAQ: ADPT) stands at the intersection of healthcare and biotechnology, with a focus on decoding the immune system to advance the diagnosis and..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Eyeing a 22% Upside Potential with Strong Buy Ratings

Amneal Pharmaceuticals, Inc. (NASDAQ: AMRX) is currently drawing significant attention from investors, and for good reason. With a market capitalization of $3.22 billion, this U.S.-based healthcare..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds